AAAAAA
Results: 1-25/61
Authors:
KAY MA
Citation: Ma. Kay, HEPATIC GENE-THERAPY FOR HEMOPHILIA-B, Haemophilia, 4(4), 1998, pp. 389-392
Authors:
MIAO CH
SNYDER RO
SCHOWALTER DB
PATIJN GA
DONAHUE B
WINTHER B
KAY MA
Citation: Ch. Miao et al., THE KINETICS OF RAAV INTEGRATION IN THE LIVER, Nature genetics, 19(1), 1998, pp. 13-15
Authors:
MIZUGUCHI H
KAY MA
Citation: H. Mizuguchi et Ma. Kay, EFFICIENT CONSTRUCTION OF A RECOMBINANT ADENOVIRUS VECTOR BY AN IMPROVED IN-VITRO LIGATION METHOD, Human gene therapy, 9(17), 1998, pp. 2577-2583
Authors:
PATIJN GA
LIEBER A
MEUSE L
WINTHER B
KAY MA
Citation: Ga. Patijn et al., HIGH-EFFICIENCY RETROVIRUS-MEDIATED GENE-TRANSFER INTO THE LIVERS OF MICE, Human gene therapy, 9(10), 1998, pp. 1449-1456
Authors:
PATIJN GA
LIEBER A
SCHOWALTER DB
SCHWALL R
TERPSTRA OT
KAY MA
Citation: Ga. Patijn et al., HEPATOCYTE GROWTH-FACTOR (HGF) INDUCES HIGH-LEVEL HEPATOCYTE PROLIFERATION IN-VIVO AND ALLOWS FOR EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER IN MICE, Hepatology, 28(4), 1998, pp. 52-52
Authors:
PATIJN GA
LIEBER A
SCHOWALTER DB
SCHWALL R
KAY MA
Citation: Ga. Patijn et al., HEPATOCYTE GROWTH-FACTOR INDUCES HEPATOCYTE PROLIFERATION IN-VIVO ANDALLOWS FOR EFFICIENT RETROVIRAL-MEDIATED GENE-TRANSFER IN MICE, Hepatology, 28(3), 1998, pp. 707-716
Authors:
PATIJN GA
TERPSTRA OT
KAY MA
Citation: Ga. Patijn et al., METHOD FOR CONTINUOUS-INFUSION INTO THE PORTAL-VEIN OF MICE, Laboratory animal science, 48(4), 1998, pp. 379-383
Authors:
WILSON CB
EMBREE LJ
SCHOWALTER D
ALBERT R
ARUFFO A
HOLLENBAUGH D
LINSLEY P
KAY MA
Citation: Cb. Wilson et al., TRANSIENT INHIBITION OF CD28 AND CD40 LIGAND INTERACTIONS PROLONGS ADENOVIRUS-MEDIATED TRANSGENE EXPRESSION IN THE LUNG AND FACILITATES EXPRESSION AFTER SECONDARY VECTOR ADMINISTRATION, Journal of virology, 72(9), 1998, pp. 7542-7550
Authors:
LIEBER A
HE CY
MEUSE L
HIMEDA C
WILSON C
KAY MA
Citation: A. Lieber et al., INHIBITION OF NF-KAPPA-B ACTIVATION IN COMBINATION WITH BCL-2 EXPRESSION ALLOWS FOR PERSISTENCE OF FIRST-GENERATION ADENOVIRUS VECTORS IN THE MOUSE-LIVER, Journal of virology (Print), 72(11), 1998, pp. 9267-9277
Authors:
KAY MA
FAUSTO N
Citation: Ma. Kay et N. Fausto, LIVER-REGENERATION - PROSPECTS FOR THERAPY BASED ON NEW TECHNOLOGIES, Molecular medicine today, 3(3), 1997, pp. 108-115
Authors:
LIEBER A
HE CY
KAY MA
Citation: A. Lieber et al., ADENOVIRAL PRETERMINAL PROTEIN STABILIZES MINI-ADENOVIRAL GENOMES IN-VITRO AND IN-VIVO, Nature biotechnology, 15(13), 1997, pp. 1383-1387
Authors:
SNYDER RO
MIAO CH
PATIJN GA
SPRATT SK
DANOS O
NAGY D
GOWN AM
WINTHER B
MEUSE L
COHEN LK
THOMPSON AR
KAY MA
Citation: Ro. Snyder et al., PERSISTENT AND THERAPEUTIC CONCENTRATIONS OF HUMAN FACTOR-IX IN MICE AFTER HEPATIC GENE-TRANSFER OF RECOMBINANT AAV VECTORS, Nature genetics, 16(3), 1997, pp. 270-276
Authors:
SCHOWALTER DB
MEUSE L
WILSON CB
LINSLEY PS
KAY MA
Citation: Db. Schowalter et al., CONSTITUTIVE EXPRESSION OF MURINE CTLA4IG FROM A RECOMBINANT ADENOVIRUS VECTOR RESULTS IN PROLONGED TRANSGENE EXPRESSION, Gene therapy, 4(8), 1997, pp. 853-860
Authors:
SCHOWALTER DB
TUBB JC
LIU M
WILSON CB
KAY MA
Citation: Db. Schowalter et al., HETEROLOGOUS EXPRESSION OF ADENOVIRUS E3-GP19K IN AN E1A-DELETED ADENOVIRUS VECTOR INHIBITS MHC-I EXPRESSION IN-VITRO, BUT DOES NOT PROLONGTRANSGENE EXPRESSION IN-VIVO, Gene therapy, 4(4), 1997, pp. 351-360
Authors:
BRAND K
ARNOLD W
BARTELS T
LIEBER A
KAY MA
STRAUSS M
DORKEN B
Citation: K. Brand et al., LIVER-ASSOCIATED TOXICITY OF THE HSV-TK GCV APPROACH AND ADENOVIRAL VECTORS/, Cancer gene therapy, 4(1), 1997, pp. 9-16
Authors:
PEETERS MJTFDV
PATIJN GA
LIEBER A
PERKINS J
KAY MA
Citation: Mjtfdv. Peeters et al., EXPANSION OF DONOR HEPATOCYTES AFTER RECOMBINANT ADENOVIRUS-INDUCED LIVER-REGENERATION IN MICE, Hepatology, 25(4), 1997, pp. 884-888
Authors:
SCHOWALTER DB
KAY MA
Citation: Db. Schowalter et Ma. Kay, GENE-THERAPY - A STATUS-REPORT, Pediatric annals, 26(9), 1997, pp. 562-568
Authors:
BETHUNE C
BUI T
LIU ML
KAY MA
HO RJY
Citation: C. Bethune et al., DEVELOPMENT OF A HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR G418 SULFATE (GENETICIN), Antimicrobial agents and chemotherapy, 41(3), 1997, pp. 661-664
Authors:
KAY MA
MEUSE L
GOWN AM
LINSLEY P
HOLLENBAUGH D
ARUFFO A
OCHS HD
WILSON CB
Citation: Ma. Kay et al., TRANSIENT IMMUNOMODULATION WITH ANTI-CD40 LIGAND ANTIBODY AND CTLA4IGENHANCES PERSISTENCE AND SECONDARY ADENOVIRUS-MEDIATED GENE-TRANSFER INTO MOUSE-LIVER, Proceedings of the National Academy of Sciences of the United Statesof America, 94(9), 1997, pp. 4686-4691
Authors:
KAY MA
LIU DX
HOOGERBRUGGE PM
Citation: Ma. Kay et al., GENE-THERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 94(24), 1997, pp. 12744-12746
Authors:
LIEBER A
HE CY
MEUSE L
SCHOWALTER D
KIRILLOVA I
WINTHER B
KAY MA
Citation: A. Lieber et al., THE ROLE OF KUPFFER CELL ACTIVATION AND VIRAL GENE-EXPRESSION IN EARLY LIVER TOXICITY AFTER INFUSION OF RECOMBINANT ADENOVIRUS VECTORS, Journal of virology, 71(11), 1997, pp. 8798-8807
Authors:
NELSON JE
KAY MA
Citation: Je. Nelson et Ma. Kay, PERSISTENCE OF RECOMBINANT ADENOVIRUS IN-VIVO IS NOT DEPENDENT ON VECTOR DNA-REPLICATION, Journal of virology, 71(11), 1997, pp. 8902-8907
Authors:
KAY MA
Citation: Ma. Kay, ADENOVIRAL VECTORS FOR HEPATIC GENE-TRANSFER IN ANIMALS, Chest, 111(6), 1997, pp. 138-142
Authors:
BENNETT RL
KARAYIORGOU M
SOBIN CA
NORWOOD TH
KAY MA
Citation: Rl. Bennett et al., IDENTIFICATION OF AN INTERSTITIAL DELETION IN AN ADULT FEMALE WITH SCHIZOPHRENIA, MENTAL-RETARDATION, AND DYSMORPHIC FEATURES - FURTHER SUPPORT FOR A PUTATIVE SCHIZOPHRENIA-SUSCEPTIBILITY LOCUS AT 5Q21-23.1, American journal of human genetics, 61(6), 1997, pp. 1450-1454
Authors:
PEETERS MJTFDV
PATIJN GA
LIEBER A
MEUSE L
KAY MA
Citation: Mjtfdv. Peeters et al., ADENOVIRUS-MEDIATED HEPATIC GENE-TRANSFER IN MICE - COMPARISON OF INTRAVASCULAR AND BILIARY ADMINISTRATION, Human gene therapy, 7(14), 1996, pp. 1693-1699